Somatic Activating PIK3CA Mutations Cause Venous Malformation.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Human Genetics

• Publication date

  2015-12-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajhg.2015.11.011PMID 26637981PMCID PMC4678782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

  2015influential reference
• Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.

  2015cited by this paper
• Common and specific effects of TIE2 mutations causing venous malformations.

  2015influential reference
• Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations.

  2015cited by this paper
• PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

  2014cited by this paper
• Clinical Delineation and Natural History of the PIK3CA-Related Overgrowth Spectrum**

  2014cited by this paper
• Activation of diverse signaling pathways by oncogenic PIK3CA mutations

  2014cited by this paper
• AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation

  2014cited by this paper
• Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.

  2013cited by this paper
• Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations

  2013cited by this paper
• PIK3CA Activating Mutations in Facial Infiltrating Lipomatosis

  2013cited by this paper
• Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.

  2013cited by this paper
• Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly

  2012cited by this paper
• De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

  2012cited by this paper
• Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.

  2012cited by this paper
• De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly

  2012cited by this paper
• Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA

  2012cited by this paper
• Venous malformation: update on aetiopathogenesis, diagnosis and management

  2010influential reference
• Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects

  2010cited by this paper
• Elevated D-dimer level in the differential diagnosis of venous malformations.

  2009influential reference
• Association of localized intravascular coagulopathy with venous malformations.

  2008influential reference
• Somatic Mutations in the Angiopoietin-Receptor TIE2 Can Cause Both Solitary and Multiple Sporadic Venous Malformations

  2008cited by this paper
• Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration

  2008cited by this paper
• High Frequency of Mutations of the PIK3CA Gene in Human Cancers

  2004cited by this paper
• Oncogenic mutations of PIK3CA in human cancers.

  2004cited by this paper
• Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics.

  2003cited by this paper
• A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

  1996cited by this paper
• Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.

  1996cited by this paper

• Differentiated In Vitro Efficacy of BYL719, ARQ092, and Rapamycin on Fibroblasts Isolated From a Chinese PIK3CA-Related Overgrowth Spectrum Individual With a Novel Variant.

  2026cites this paper
• Molecular Characterization of Vascular Anomalies Tissues Guides Clinical Diagnosis.

  2026cites this paper
• Somatic genomics as a discovery engine for biomedicine.

  2026cites this paper
• Advances in genetics, signaling, and modeling of venous malformations.

  2026cites this paper
• Theragnostic approach of venous malformations in 2025: similarities and differences with oncology advances.

  2025cites this paper
• In‐Utero Therapy for Fetal Vascular Anomalies: Efficacy and Tolerance of Sirolimus Administered to the Pregnant Patient

  2025cites this paper
• Giant hepatic hemangioma in a Japanese adult patient reduced by sirolimus therapy

  2025cites this paper
• TEK-related venous malformation of the orofacial region: report of a case with multidisciplinary treatment guided by molecular diagnosis.

  2025cites this paper
• Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations

  2025cites this paper
• Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital

  2025cites this paper
• Trastornos que afectan a la vascularización cutánea: malformaciones vasculares

  2025cites this paper
• Cellular Heterogeneity and Tissue Specificity in Venous Malformations: Implications for Pathogenesis and Targeted Therapies.

  2025cites this paper
• DDIT4 knockdown suppresses venous malformation progression by inhibiting NF-κB signaling as a potential therapeutic target.

  2025cites this paper
• Semaphorin 3A and 3F overexpression in TIE2 hyperactive endothelial cells contribute to the pathological lumen expansion in venous malformation

  2025cites this paper
• The Role of Somatic Mutation in Hereditary Hemorrhagic Telangiectasia Pathogenesis

  2025cites this paper
• Étiopathogénie des malformations vasculaires. Quel lien avec le cancer ?

  2025cites this paper
• Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes

  2025cites this paper
• Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformations

  2025cites this paper
• Somatic uniparental disomy of PTEN in endothelial cells causes vascular malformations in patients with PTEN Hamartoma Tumor Syndrome.

  2025cites this paper
• Global research trends and basis of venous/lymphatic malformations during 2003–2023: a bibliometric study over two decades

  2025cites this paper
• Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

  2025cites this paper
• Angiomatosis of soft tissue

  2025cites this paper
• The power of five - inositol polyphosphate 5-phosphatase gene mutations at the intersection of development and disease.

  2025cites this paper
• Microfluidic vessel-on-chip platform for investigation of cellular defects in venous malformations and responses to various shear stress and flow conditions.

  2025cites this paper
• Ultra-deep targeted next-generation sequencing with peripheral blood in patients with vascular malformations: a cohort of 40 patients

  2025influential citation
• Evolving medical treatment for vascular malformation.

  2025cites this paper
• Targeted Medical Therapies for Vascular Anomalies: A Clinical Review

  2025cites this paper
• Mosaicism of Vascular Origin

  2025cites this paper
• Genetic mutation and blue rubber bleb nevus syndrome: case reports and literature review

  2025cites this paper
• A phase 2 randomized, double-blind trial of ART-001, a selective PI3Kα inhibitor, for the treatment of slow-flow vascular malformations

  2025cites this paper
• Thoracic Giant Venous Malformation in a Stillbirth with Pik3ca Somatic Mutation

  2025cites this paper
• Case Report: Upper extremity fibro-adipose vascular anomaly

  2025cites this paper
• Genetic aspects of vascular malformations.

  2025cites this paper
• Adding to Your Tool Box: Laser Therapy for Vascular Anomalies

  2025cites this paper
• Targeted Therapies for Slow‐Flow Vascular Malformations

  2025cites this paper
• Schmerzhaftes Rückensymptom bei einem Kleinkind – venöse Malformation mit Thrombosierung

  2025cites this paper
• Venous Malformations: Unraveling Latest Mechanisms and Bridging Gaps in Targeted Therapy Development

  2025influential citation
• High depth targeted next-generation sequencing in vascular malformations.

  2025cites this paper
• Vascular malformations: from genetics to therapeutics

  2025cites this paper
• Medikamentöse Therapien vaskulärer Malformationen

  2025cites this paper
• Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling.

  2025cites this paper
• Research Progress of Blue Rubber Bleb Nevus Syndrome

  2025cites this paper
• PI3K/AKT/mTOR axis in vascular malformations: from molecular insights to targeted clinical trials

  2025cites this paper
• Troubles affectant la vascularisation cutanée : malformations vasculaires

  2024cites this paper
• Histopathological characteristics of vascular anomalies of the maxillofacial region in young children

  2024cites this paper
• Cerebral vascular malformations: pathogenesis and therapy

  2024cites this paper
• Alk1/Endoglin signaling restricts vein cell size increases in response to hemodynamic cues

  2024cites this paper
• Molecular landscape and classification of vascular anomalies.

  2024cites this paper
• Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-driven refractory vascular malformations

  2024influential citation
• Targeted Treatments for Vascular Malformations: Current State of the Art.

  2024cites this paper
• Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations

  2024cites this paper
• Venous Malformations: Diagnosis, Management, and Future Directions

  2024cites this paper
• Congenital Vascular and Lymphatic Diseases.

  2024cites this paper
• Non‐Hotspot PIK3CA Variants Have Higher Variant Allele Frequency and are More Common in Syndromic Vascular Malformations

  2024cites this paper
• Threshold of somatic mosaicism leading to brain dysfunction with focal epilepsy.

  2024cites this paper
• The Role of Medical Management in Vascular Anomalies

  2024cites this paper
• Vascular Malformations

  2024cites this paper
• Interdisziplinäres Management vaskulärer Anomalien im Kopf-Hals-Bereich

  2024cites this paper
• Shear stress and pathophysiological PI3K involvement in vascular malformations

  2024cites this paper
• Comprehensive phenotypic and genomic characterization of venous malformations.

  2024cites this paper
• Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers

  2024cites this paper
• Developmental Venous Anomalies.

  2024cites this paper
• Direct oral anticoagulants and venous malformations: literature review and retrospective study of 29 patients

  2024cites this paper
• Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells

  2024cites this paper
• Somatic loss-of-function PIK3R1 and activating non-hotspot PIK3CA mutations associated with Capillary Malformation with Dilated Veins (CMDV).

  2024cites this paper
• Assessing coagulopathy and endothelial dysfunction in pediatric venous malformation: A thromboelastometry and syndecan‐1 study

  2024cites this paper
• The Economic Consequences of Sirolimus Treatment in Patients With Vascular Malformations

  2024cites this paper
• Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition

  2024cites this paper
• Progressive vascular tumor in infant: A case report and literature review of PIK3CA vascular malformation

  2024cites this paper
• Assessment of gene–disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA

  2024cites this paper
• PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments.

  2024cites this paper
• Targeted therapy for capillary-venous malformations

  2024cites this paper
• Updates in Genetic Testing for Head and Neck Vascular Anomalies.

  2023cites this paper
• Defining the functional influence of endothelial cell-expressed oncogenic activating mutations on vascular morphogenesis and capillary assembly.

  2023cites this paper
• Multiple congenital malformations arise from somatic mosaicism for constitutively active Pik3ca signalling

  2023cites this paper
• Somatic mutation spectrum of a Chinese cohort of pediatrics with vascular malformations

  2023cites this paper
• Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations

  2023cites this paper
• ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component

  2023influential citation
• International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

  2023cites this paper
• Contemporary management of extracranial vascular malformations

  2023cites this paper
• p-AKT/VPS4B regulates the small extracellular vesicle size in venous malformation endothelial cells.

  2023cites this paper
• Pathophysiology of Slow-Flow Vascular Malformations: Current Understanding and Unanswered Questions

  2023cites this paper
• A proposal for a revision of the phlebographic classification of congenital venous malformations

  2023cites this paper
• Fibroadipose vascular anomaly: a clinicopathological study of 75 cases

  2023cites this paper
• Clinical phenotype of adolescent and adult patients with extracranial vascular malformation.

  2023cites this paper
• Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations

  2023cites this paper
• Ablation of Venous Malformations by Photothermal Therapy with Intravenous Gold Nanoshells.

  2023cites this paper
• Plasma Cell-Free DNA After Embolization

  2023cites this paper
• 3D printing personalized guide plate in the management of recurrent intramuscular venous malformations: A single center experience

  2023cites this paper
• Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation

  2023cites this paper
• Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel–Trenaunay syndrome in an Asian population

  2023cites this paper
• Shaping the brain vasculature in development and disease in the single-cell era

  2023cites this paper
• Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation

  2023influential citation
• Activity of a TIE2 inhibitor (rebastinib) in a patient with a life‐threatening cervicofacial venous malformation

  2023cites this paper
• Genetic mutations and phenotype characteristics in peripheral vascular malformations: A systematic review

  2023cites this paper
• Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy

  2023influential citation
• A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of ART‐001 with a novel oral pediatric formulation in healthy subjects

  2023cites this paper
• Surgical Treatment of Vascular Anomalies in the Extremities: A Single Surgeon Experience

  2023cites this paper
• The VASCERN-VASCA Working Group Diagnostic and Management Pathways for Venous Malformations

  2023cites this paper
• Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial

  2022cites this paper